CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sinil Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sinil Pharmaceutical Co Ltd
28, Boksanggol-gil, Angseong-myeon
Phone: +82 437223300p:+82 437223300 CHUNGJU, 27304  South Korea Ticker: 012790012790
Business Summary
Sinil Pharmaceutical Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Business segment provides analgesics and anti-inflammatory drugs, hyperlipidemia treatments, skin disease treatments, folic acid deficiency treatments, as well as treatments for other diseases. The Cosmetics Business segment is engaged in the provision of skin care cosmetics. The Real Estate Business segment engages in the real estate rental business. The Health Functional Food Business segment provides vitamin supplements. The Quasi-Pharmaceutical Business segment provides yellow dust masks.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations
6512 Operators of nonresidential buildings
2099 Food preparations, not elsewhere classified
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Seong SoHong 75 1/1/2009
Chief Executive Officer, Director Jae HyeonHong 47 12/24/2018 3/17/2006
Internal Auditor Se MukChoi 51
4 additional Officers and Directors records available in full report.

Business Names
Business Name
012790
Shinil Pharmaceutical Co., Ltd.

General Information
Number of Employees: 413 (As of 12/31/2025)
Outstanding Shares: 11,559,561 (As of 12/31/2025)
Shareholders: 17,993
Stock Exchange: KDQ
Fax Number: +82 438553944


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 31, 2026